Literature DB >> 20610232

Upregulation of monocyte proinflammatory cytokine production by C-reactive protein is significantly related to ongoing myocardial damage and future cardiac events in patients with chronic heart failure.

Akihiro Nakagomi1, Yoshihiko Seino, Yasumi Endoh, Yoshiki Kusama, Hirotsugu Atarashi, Kyoichi Mizuno.   

Abstract

BACKGROUND: An elevation of the cardiac troponin T (TnT) level identifies patients with ongoing myocardial damage (OMD) and at increased risk for future cardiac events in chronic heart failure (CHF). C-reactive protein (CRP) upregulates monocyte proinflammatory cytokine production and this upregulation appears to play an important role on OMD. METHODS AND
RESULTS: Peripheral blood mononuclear cells (PBMCs) were stimulated by 25 microg/mL CRP in 72 patients with CHF. Tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 production by monocytes was measured by a specific enzyme-linked immunosorbent assay and expressed as the mean +/- SD (pg x mL x 10(6) PBMCs). The patients were divided into 2 groups according to the TnT levels: 27 patients with OMD (TnT >/= 0.01 ng/mL) and 45 patients without OMD. CRP-induced cytokine production was upregulated significantly more in patients with OMD than in those without OMD (TNF-alpha: 200.6 +/- 100.4 vs. 102.1 +/- 73.6 pg/mL, P < .001, IL-6: 4611.7 +/- 2600.0 vs. 1451.6 +/- 1193.5 pg/mL, P < .001). Multivariate Cox regression analyses revealed that CRP-stimulated monocyte production of TNF-alpha >/= 120 pg/mL and TnT >/= 0.03 ng/mL were independent predictors of cardiac events.
CONCLUSIONS: The upregulation of monocyte proinflammatory cytokine production by CRP could be significantly related to OMD and future cardiac events in CHF. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610232     DOI: 10.1016/j.cardfail.2010.02.003

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  5 in total

1.  The profile of the systemic inflammatory response in children undergoing ventricular assist device support.

Authors:  Xiaoyang Yu; Bodil Larsen; Jennifer Rutledge; Lori West; David B Ross; Ivan M Rebeyka; Holger Buchholz; Jia Li
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-22

2.  Impact of sleep-disordered breathing on myocardial damage and metabolism in patients with chronic heart failure.

Authors:  Makiko Miyata; Akiomi Yoshihisa; Hiroyuki Yamauchi; Takashi Owada; Takamasa Sato; Satoshi Suzuki; Koichi Sugimoto; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Shu-Ichi Saitoh; Yasuchika Takeishi
Journal:  Heart Vessels       Date:  2014-01-31       Impact factor: 2.037

3.  Inflammatory activation following interruption of long-term cardiac resynchronization therapy.

Authors:  Andrzej Rubaj; Piotr Ruciński; Krzysztof Oleszczak; Michał K Trojnar; Maciej Wójcik; Andrzej Wysokiński; Andrzej Kutarski
Journal:  Heart Vessels       Date:  2012-12-16       Impact factor: 2.037

4.  Molecular mechanisms behind progressing chronic inflammatory dilated cardiomyopathy.

Authors:  Daiva Bironaite; Dainius Daunoravicius; Julius Bogomolovas; Sigitas Cibiras; Dalius Vitkus; Edvardas Zurauskas; Ieva Zasytyte; Kestutis Rucinskas; Siegfried Labeit; Algirdas Venalis; Virginija Grabauskiene
Journal:  BMC Cardiovasc Disord       Date:  2015-03-26       Impact factor: 2.298

5.  Excretion of urinary orosomucoid 1 protein is elevated in patients with chronic heart failure.

Authors:  Li-na Hou; Fei Li; Qing-chun Zeng; Liang Su; Ping-an Chen; Zhi-hao Xu; Din-ji Zhu; Chang-hua Liu; Ding-li Xu
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.